InMode (INMD) Cash from Investing Activities Growth (3y) (2021 - 2026)
Powered by 
Analysis
InMode (INMD) Cash from Investing Activities Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 17.83% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -26.99% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -44.28% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -6.23% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -32.54% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -68.12% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 18.69% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 37.39% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -17.67% |
| 10 | InMode | 944.68 Mn | 462.56 Mn | 71.52 Mn | 42.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.56% |
| Mar 31, 2026 | 81.30% |
| Dec 31, 2025 | 39.44% |
| Sep 30, 2025 | 30.21% |
| Jun 30, 2025 | 218.09% |
| Mar 31, 2025 | 99.56% |
| Dec 31, 2024 | 65.41% |
| Sep 30, 2024 | 63.48% |
| Jun 30, 2024 | 34.02% |
| Mar 31, 2024 | -8.01% |
| Dec 31, 2023 | -25.05% |
| Sep 30, 2023 | -37.16% |
| Jun 30, 2023 | -9.61% |
| Mar 31, 2023 | -54.46% |
| Dec 31, 2022 | -6.59% |
| Sep 30, 2022 | 4.06% |
| Jun 30, 2022 | 34.88% |
| Mar 31, 2022 | -13.45% |
| Dec 31, 2021 | -79.67% |
| Sep 30, 2021 | -34.94% |